TY - JOUR
T1 - Clinical advances in obsessive-compulsive disorder
T2 - A position statement by the International College of Obsessive-Compulsive Spectrum Disorders
AU - Fineberg, Naomi A.
AU - Hollander, Eric
AU - Pallanti, Stefano
AU - Walitza, Susanne
AU - Grünblatt, Edna
AU - Dell'Osso, Bernardo Maria
AU - Albert, Umberto
AU - Geller, Daniel A.
AU - Brakoulias, Vlasios
AU - Janardhan Reddy, Y. C.
AU - Arumugham, Shyam Sundar
AU - Shavitt, Roseli G.
AU - Drummond, Lynne
AU - Grancini, Benedetta
AU - De Carlo, Vera
AU - Cinosi, Eduardo
AU - Chamberlain, Samuel R.
AU - Ioannidis, Konstantinos
AU - Rodriguez, Carolyn I.
AU - Garg, Kabir
AU - Castle, David
AU - Van Ameringen, Michael
AU - Stein, Dan J.
AU - Carmi, Lior
AU - Zohar, Joseph
AU - Menchon, Jose M.
N1 - Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020
Y1 - 2020
N2 - In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
AB - In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
KW - evidence based
KW - obsessive-compulsive disorder
KW - position statement
KW - treatments
UR - http://www.scopus.com/inward/record.url?scp=85085883572&partnerID=8YFLogxK
U2 - 10.1097/YIC.0000000000000314
DO - 10.1097/YIC.0000000000000314
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 32433254
AN - SCOPUS:85085883572
SN - 0268-1315
SP - 173
EP - 193
JO - International Clinical Psychopharmacology
JF - International Clinical Psychopharmacology
ER -